chr1-74026887-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105659.2(LRRIQ3):āc.1801C>Gā(p.Gln601Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,454,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001105659.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRIQ3 | NM_001105659.2 | c.1801C>G | p.Gln601Glu | missense_variant | 8/8 | ENST00000354431.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRIQ3 | ENST00000354431.9 | c.1801C>G | p.Gln601Glu | missense_variant | 8/8 | 5 | NM_001105659.2 | P2 | |
LRRIQ3 | ENST00000395089.5 | c.1801C>G | p.Gln601Glu | missense_variant | 7/7 | 5 | P2 | ||
LRRIQ3 | ENST00000417067.5 | c.*30C>G | 3_prime_UTR_variant | 2/2 | 2 | ||||
LRRIQ3 | ENST00000415760.5 | c.*2786C>G | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1454898Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 723910
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.1801C>G (p.Q601E) alteration is located in exon 8 (coding exon 7) of the LRRIQ3 gene. This alteration results from a C to G substitution at nucleotide position 1801, causing the glutamine (Q) at amino acid position 601 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at